Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Antimicrobial Agents and Chemotherapy Année : 2015

Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus

Résumé

The production of β-lactamases Bla Mab and BlaC contributes to β-lactam resistance in Mycobacterium abscessus and Mycobacterium tuberculosis, respectively. Ceftaroline was efficiently hydrolyzed by these enzymes. Inhibition of M. tuberculosis BlaC by clavulanate decreased the ceftaroline MIC from >256 to 16 to 64 g/ml, but these values are clinically irrelevant. In contrast, the ceftaroline-avibactam combination should be evaluated against M. abscessus since it inhibited growth at lower and potentially achievable drug concentrations.

Domaines

Bactériologie
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03400785 , version 1 (25-10-2021)

Identifiants

Citer

Vincent Dubée Dubée, Daria Soroka, Mélanie Cortes, Anne-Laure Lefebvre, Laurent Gutmann, et al.. Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy, 2015, 59 (5), pp.2938 - 2941. ⟨10.1128/aac.05080-14⟩. ⟨inserm-03400785⟩
22 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More